(S)-2-(3-(4-hexylphenyl)-1,2,4-oxadiazol-5-yl)pyrrolidine-1-carboximidamide hydrochloride

ID: ALA3627771

Chembl Id: CHEMBL3627771

PubChem CID: 122192892

Max Phase: Preclinical

Molecular Formula: C19H28ClN5O

Molecular Weight: 341.46

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCc1ccc(-c2noc([C@@H]3CCCN3C(=N)N)n2)cc1.Cl

Standard InChI:  InChI=1S/C19H27N5O.ClH/c1-2-3-4-5-7-14-9-11-15(12-10-14)17-22-18(25-23-17)16-8-6-13-24(16)19(20)21;/h9-12,16H,2-8,13H2,1H3,(H3,20,21);1H/t16-;/m0./s1

Standard InChI Key:  ZDZPTXUAQZQBCV-NTISSMGPSA-N

Associated Targets(Human)

SPHK1 Tchem Sphingosine kinase 1 (1990 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Sphk2 Sphingosine kinase 2 (214 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 341.46Molecular Weight (Monoisotopic): 341.2216AlogP: 3.89#Rotatable Bonds: 7
Polar Surface Area: 92.03Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 11.32CX LogP: 4.97CX LogD: 2.50
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.45Np Likeness Score: -0.86

References

1. Congdon MD, Childress ES, Patwardhan NN, Gumkowski J, Morris EA, Kharel Y, Lynch KR, Santos WL..  (2015)  Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors.,  25  (21): [PMID:25862200] [10.1016/j.bmcl.2015.03.041]

Source